IDENT-A-DRUG REFERENCE 3816 P99 - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 75791725
Serial Number
75791725
Word Mark
IDENT-A-DRUG REFERENCE 3816 P99
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2000-09-08
Filing Date
1999-09-07
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
010702, 100901, 260118, 260121, 261701, 261705 - Globes with meridians and parallel lines only. Medicines and nonmedical products in tablet, capsule or powder form; suppositories. Three or more concentric circles. Circles that are totally or partially shaded. Straight line(s), band(s) or bar(s). Horizontal line(s), band(s) or bar(s).
Law Office Assigned Location Code
L50
Employee Name
RUTLAND, BARBARA A
Statements
Goods and Services
reference that identifies pills, tablent, capsules, etc by the code numbers imprinted on them
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
1999-11-26
Primary Code
005
First Use Anywhere Date
1999-03-03
First Use In Commerce Date
1999-03-03
Correspondences
Name
THERAPEUTIC RESEARCH CENTER
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
1999-12-17ASSIGNED TO EXAMINER
2000-01-12NON-FINAL ACTION MAILED
2000-09-08ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE